447 related articles for article (PubMed ID: 11020798)
1. Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin.
Chen CT; Lin J; Li Q; Phipps SS; Jakubczak JL; Stewart DA; Skripchenko Y; Forry-Schaudies S; Wood J; Schnell C; Hallenbeck PL
Hum Gene Ther; 2000 Sep; 11(14):1983-96. PubMed ID: 11020798
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of viral vector-mediated antiangiogenic gene transfer in malignant ascites.
Hampl M; Tanaka T; Albert PS; Lee J; Ferrari N; Fine HA
Hum Gene Ther; 2001 Sep; 12(14):1713-29. PubMed ID: 11560766
[TBL] [Abstract][Full Text] [Related]
3. Development of lentiviral vectors for antiangiogenic gene delivery.
Shichinohe T; Bochner BH; Mizutani K; Nishida M; Hegerich-Gilliam S; Naldini L; Kasahara N
Cancer Gene Ther; 2001 Nov; 8(11):879-89. PubMed ID: 11773978
[TBL] [Abstract][Full Text] [Related]
4. Adenoviral vectors expressing human endostatin-angiostatin and soluble Tie2: enhanced suppression of tumor growth and antiangiogenic effects in a prostate tumor model.
Raikwar SP; Temm CJ; Raikwar NS; Kao C; Molitoris BA; Gardner TA
Mol Ther; 2005 Dec; 12(6):1091-100. PubMed ID: 16169279
[TBL] [Abstract][Full Text] [Related]
5. Endostatin exhibits a direct antitumor effect in addition to its antiangiogenic activity in colon cancer cells.
Dkhissi F; Lu H; Soria C; Opolon P; Griscelli F; Liu H; Khattar P; Mishal Z; Perricaudet M; Li H
Hum Gene Ther; 2003 Jul; 14(10):997-1008. PubMed ID: 12869217
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin.
Mori K; Ando A; Gehlbach P; Nesbitt D; Takahashi K; Goldsteen D; Penn M; Chen CT; Mori K; Melia M; Phipps S; Moffat D; Brazzell K; Liau G; Dixon KH; Campochiaro PA
Am J Pathol; 2001 Jul; 159(1):313-20. PubMed ID: 11438478
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated human endostatin gene delivery demonstrates strain-specific antitumor activity and acute dose-dependent toxicity in mice.
Wen XY; Bai Y; Stewart AK
Hum Gene Ther; 2001 Mar; 12(4):347-58. PubMed ID: 11242527
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas.
Ding I; Sun JZ; Fenton B; Liu WM; Kimsely P; Okunieff P; Min W
Cancer Res; 2001 Jan; 61(2):526-31. PubMed ID: 11212245
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic and antitumor effects of endostatin on follicular thyroid carcinoma.
Ye C; Feng C; Wang S; Liu X; Lin Y; Li M
Endocrinology; 2002 Sep; 143(9):3522-8. PubMed ID: 12193566
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases.
Sauter BV; Martinet O; Zhang WJ; Mandeli J; Woo SL
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4802-7. PubMed ID: 10758166
[TBL] [Abstract][Full Text] [Related]
11. Induction of therapeutic antitumor antiangiogenesis by intratumoral injection of genetically engineered endostatin-producing Semliki Forest virus.
Yamanaka R; Zullo SA; Ramsey J; Onodera M; Tanaka R; Blaese M; Xanthopoulos KG
Cancer Gene Ther; 2001 Oct; 8(10):796-802. PubMed ID: 11687903
[TBL] [Abstract][Full Text] [Related]
12. The antitumoral effect of endostatin and angiostatin is associated with a down-regulation of vascular endothelial growth factor expression in tumor cells.
Hajitou A; Grignet C; Devy L; Berndt S; Blacher S; Deroanne CF; Bajou K; Fong T; Chiang Y; Foidart JM; Noël A
FASEB J; 2002 Nov; 16(13):1802-4. PubMed ID: 12354694
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated endostatin delivery results in inhibition of mammary gland tumor growth in C3(1)/SV40 T-antigen transgenic mice.
Calvo A; Feldman AL; Libutti SK; Green JE
Cancer Res; 2002 Jul; 62(14):3934-8. PubMed ID: 12124322
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo.
Jin X; Bookstein R; Wills K; Avanzini J; Tsai V; LaFace D; Terracina G; Shi B; Nielsen LL
Cancer Gene Ther; 2001 Dec; 8(12):982-9. PubMed ID: 11781661
[TBL] [Abstract][Full Text] [Related]
15. Enhanced antiangiogenic therapy of squamous cell carcinoma by combined endostatin and epidermal growth factor receptor-antisense therapy.
Li M; Ye C; Feng C; Riedel F; Liu X; Zeng Q; Grandis JR
Clin Cancer Res; 2002 Nov; 8(11):3570-8. PubMed ID: 12429648
[TBL] [Abstract][Full Text] [Related]
16. Concurrent delivery of GM-CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors.
Tai KF; Chen PJ; Chen DS; Hwang LH
J Gene Med; 2003 May; 5(5):386-98. PubMed ID: 12731087
[TBL] [Abstract][Full Text] [Related]
17. Adeno-associated virus-mediated gene transfer of endostatin inhibits angiogenesis and tumor growth in vivo.
Shi W; Teschendorf C; Muzyczka N; Siemann DW
Cancer Gene Ther; 2002 Jun; 9(6):513-21. PubMed ID: 12032662
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin.
Calvo A; Yokoyama Y; Smith LE; Ali I; Shih SC; Feldman AL; Libutti SK; Sundaram R; Green JE
Int J Cancer; 2002 Sep; 101(3):224-34. PubMed ID: 12209972
[TBL] [Abstract][Full Text] [Related]
19. [Inhibition of tumor growth and metastasis via local administration of recombinant human endostatin adenovirus].
Wu Y; Yang L; Zhao X; Su JM; Hu B; Liu JY; Niu T; Luo Y; Li Q; Wei YQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):557-61. PubMed ID: 15583981
[TBL] [Abstract][Full Text] [Related]
20. Human endostatin inhibits growth of human non-small-cell lung cancer in a murine xenotransplant model.
Boehle AS; Kurdow R; Schulze M; Kliche U; Sipos B; Soondrum K; Ebrahimnejad A; Dohrmann P; Kalthoff H; Henne-Bruns D; Neumaier M
Int J Cancer; 2001 Nov; 94(3):420-8. PubMed ID: 11745424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
